Yahoo
NasdaqGM - Delayed Quote USD

Oaktree Acquisition Corp. III Life Sciences (OACC)

10.72 0.00 (0.00%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
Total Revenue
0
0
Operating Expense
1,199.57
1,195.69
Operating Income
-1,199.57
-1,195.69
Net Non Operating Interest Income Expense
7,954
8,484.51
Pretax Income
6,754.43
7,288.82
Net Income Common Stockholders
6,754.43
7,288.82
Diluted NI Available to Com Stockholders
6,754.43
7,288.82
Basic EPS
0.28
0.30
Diluted EPS
0.28
0.30
Basic Average Shares
24,582.77
24,582.77
Diluted Average Shares
24,582.77
24,582.77
Total Operating Income as Reported
-1,199.57
-1,195.69
Total Expenses
1,199.57
1,195.69
Net Income from Continuing & Discontinued Operation
6,754.43
7,288.82
Normalized Income
6,754.43
7,288.82
Interest Income
7,954
8,484.51
Net Interest Income
7,954
8,484.51
EBIT
-1,199.57
-1,195.69
EBITDA
-1,199.57
-1,195.69
Net Income from Continuing Operation Net Minority Interest
6,754.43
7,288.82
Normalized EBITDA
-1,199.57
-1,195.69
Tax Rate for Calcs
0
0
Tax Effect of Unusual Items
0
0
12/31/2025 - 12/16/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: